Kimberly L. Johung, MD, PhD
Associate Professor of Therapeutic Radiology; Vice Chair for Education, Therapeutic Radiology; Director of Residency Training Program, Therapeutic Radiology; Chief, Gastrointestinal Radiotherapy Program, Therapeutic Radiology; Chief, VA Radiotherapy Program, Therapeutic Radiology
Research & Publications
Biography
News
Locations
Coauthors
Selected Publications
- Radiation Therapy for Patients with Advanced Renal Cell Carcinoma.Miccio JA, Oladeru OT, Jun Ma S, Johung KL. Radiation Therapy for Patients with Advanced Renal Cell Carcinoma. The Urologic Clinics Of North America 2020, 47: 399-411. PMID: 32600541, DOI: 10.1016/j.ucl.2020.04.011.
- A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline and Locally Advanced Unresectable Pancreatic Cancer.Cecchini M, Miccio JA, Pahade J, Lacy J, Salem RR, Johnson SB, Blakaj A, Stein S, Kortmansky JS, Johung KL. A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline and Locally Advanced Unresectable Pancreatic Cancer. Pancreas 2020, 49: 904-911. PMID: 32658074, DOI: 10.1097/MPA.0000000000001592.
- Does Chemoradiation Benefit Patients With Gastric Cancer Managed Without Surgery?Johung KL, Stein SM. Does Chemoradiation Benefit Patients With Gastric Cancer Managed Without Surgery? Journal Of The National Comprehensive Cancer Network : JNCCN 2018, 16: 1027-1028. PMID: 30099377, DOI: 10.6004/jnccn.2018.7062.
- Chemoradiation after FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer.Mancini BR, Stein S, Lloyd S, Rutter CE, James E, Chang BW, Lacy J, Johung KL. Chemoradiation after FOLFIRINOX for borderline resectable or locally advanced pancreatic cancer. Journal Of Gastrointestinal Oncology 2018, 9: 982-988. PMID: 30603116, PMCID: PMC6286925, DOI: 10.21037/jgo.2018.04.03.
- Role of Adjuvant Treatment in Esophageal Cancer With Incidental Pathologic Node Positivity.Gao SJ, Park HS, Corso CD, Rutter CE, Kim AW, Johung KL. Role of Adjuvant Treatment in Esophageal Cancer With Incidental Pathologic Node Positivity. The Annals Of Thoracic Surgery 2017, 104: 267-274. PMID: 28456393, DOI: 10.1016/j.athoracsur.2017.01.092.
- Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer.Kole AJ, Stahl JM, Park HS, Khan SA, Johung KL. Predictors of Nonadherence to NCCN Guideline Recommendations for the Management of Stage I Anal Canal Cancer. Journal Of The National Comprehensive Cancer Network : JNCCN 2017, 15: 355-362. PMID: 28275036, DOI: 10.6004/jnccn.2017.0035.
- Post-operative radiotherapy is associated with improved survival in esophageal cancer with positive surgical margins.Gao SJ, Park HS, Corso CD, Rutter CE, Khan SA, Johung KL. Post-operative radiotherapy is associated with improved survival in esophageal cancer with positive surgical margins. Journal Of Gastrointestinal Oncology 2017, 8: 953-961. PMID: 29299354, PMCID: PMC5750177, DOI: 10.21037/jgo.2017.08.12.
- Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis.Johung KL, Yeh N, Desai NB, Williams TM, Lautenschlaeger T, Arvold ND, Ning MS, Attia A, Lovly CM, Goldberg S, Beal K, Yu JB, Kavanagh BD, Chiang VL, Camidge DR, Contessa JN. Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis. Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology 2016, 34: 123-9. PMID: 26438117, PMCID: PMC5070549, DOI: 10.1200/JCO.2015.62.0138.
- Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base.Rutter CE, Park HS, Corso CD, Lester-Coll NH, Mancini BR, Yeboa DN, Johung KL. Addition of radiotherapy to adjuvant chemotherapy is associated with improved overall survival in resected pancreatic adenocarcinoma: An analysis of the National Cancer Data Base. Cancer 2015, 121: 4141-9. PMID: 26280559, DOI: 10.1002/cncr.29652.
- A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer.Johung KL, Yao X, Li F, Yu JB, Gettinger SN, Goldberg S, Decker RH, Hess JA, Chiang VL, Contessa JN. A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer. Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research 2013, 19: 5523-32. PMID: 23897899, DOI: 10.1158/1078-0432.CCR-13-0836.